BriaCell Therapeutics Corp. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2024 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q1 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
BriaCell Therapeutics Corp. Earnings Date And Information
BriaCell Therapeutics Corp. last posted its earnings results on Monday, October 28th, 2024. The company reported $-0.07 earnings per share for the quarter, topping analysts' consensus estimates of $-0.52 by $0.45. The company had revenue of 22,671 for the quarter and had revenue of 0 for the year. BriaCell Therapeutics Corp. has generated $0 earnings per share over the last year ($-0.29 diluted earnings per share) and currently has a price-to-earnings ratio of -2.72. BriaCell Therapeutics Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 12th, 2024 based on prior year's report dates.
BriaCell Therapeutics Corp. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/28/2024 | Q4 2024 | -$0.07 | $22,671 | $22,671 | ||
| 06/14/2024 | Q3 2024 | -$0.55 | $0.11 | 0.66 | $0 | |
| 03/18/2024 | Q2 2024 | -$0.20 | -$0.71 | -0.51 | $0 | |
| 12/14/2023 | Q1 2024 | -$0.18 | $0.37 | 0.55 | $0 | |
| 10/25/2023 | Q4 2023 | -$0.40 | -$0.15 | 0.25 | $0 | |
| 06/14/2023 | Q3 2023 | -$0.36 | -$0.28 | 0.08 | $0 | |
| 03/15/2023 | Q2 2023 | -$0.77 | $0 | |||
| 12/14/2022 | Q1 2023 | -$0.33 | $0.21 | 0.54 | $0 | |
| 10/27/2022 | Q4 2022 | -$1.15 | $0 | |||
| 06/13/2022 | Q3 2022 | -$0.19 | -$0.60 | -0.41 | $0 | |
| 06/13/2022 | Q2 2022 | -$0.19 | $0.71 | 0.9 | $0 | |
| 10/29/2021 | Q1 2022 | $0.06 | $0 | |||
| 10/29/2021 | Q4 2021 | -$0.71 | $0 | |||
| 04/01/2021 | Q3 2021 | $0.49 | $0 | |||
| 04/01/2021 | Q2 2021 | $0.03 | $0 | |||
| 01/30/2021 | Q1 2021 | $0.30 | $0 | |||
| 07/30/2020 | Q4 2020 | -$1.56 | $0 | |||
| 07/30/2020 | Q3 2020 | $0.41 | $0 | |||
| 04/29/2020 | Q2 2020 | $0.69 | $0 | |||
| 01/30/2020 | Q1 2020 | $0.58 | $0 |
BriaCell Therapeutics Corp. Earnings: Frequently Asked Questions
-
When is BriaCell Therapeutics Corp.'s earnings date?
BriaCell Therapeutics Corp. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, December 12th, 2024 based off last year's report dates.
-
Did BriaCell Therapeutics Corp. beat their earnings estimates last quarter?
In the previous quarter, BriaCell Therapeutics Corp. (:BCTX) reported $-0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.52 by $0.45.
-
How can I listen to BriaCell Therapeutics Corp.'s earnings conference call?
The conference call for BriaCell Therapeutics Corp.'s latest earnings report can be listened to online.
-
How can I read BriaCell Therapeutics Corp.'s conference call transcript?
The conference call transcript for BriaCell Therapeutics Corp.'s latest earnings report can be read online.
-
How much profit does BriaCell Therapeutics Corp. generate each year?
BriaCell Therapeutics Corp. (:BCTX) has a recorded net income of $0. BriaCell Therapeutics Corp. has generated $-0.29 earnings per share over the last four quarters.
-
What is BriaCell Therapeutics Corp.'s price-to-earnings ratio?
BriaCell Therapeutics Corp. (:BCTX) has a price-to-earnings ratio of -2.72 and price/earnings-to-growth ratio is -0.03.
